Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Cynomolgus IgG1 (AM122), Unconjugated, Human

Product Overview

• Article Name: Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Cynomolgus IgG1 (AM122), Unconjugated, Human
• Biozol Catalog Number: ABS-SPD-M201-100UG
• Supplier Catalog Number: SPD-M201-100ug
• Alternative Catalog Number: ABS-SPD-M201-100UG
• Manufacturer: AcroBiosystems
• Host: Human
• Category: Antikörper
• Species Reactivity: Monkey
• Conjugation: Unconjugated

Product Description

AntiSARSCoV2 Spike RBD Neutralizing Antibody, Chimeric mAb, Cynomolgus IgG1 (AM122) (SPDM201) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with Cynomolgus IgG1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARSCoV2 Spike S1 Protein. - Antikörper

Product Properties

• Tag: Cynomolgus IgG1 | Cynomolgus Kappa
• Buffer: PBS, pH7.4
• Purity: 0.95
• Form: Powder
• Target: Spike RBD

Images

Immobilized SARS-CoV-2 Spike RBD, His Tag (Cat. No. SPD-C52H1) at 2 µg/mL (100 µL/well) can bind Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Cynomolgus IgG1 (AM122) (Cat. No. SPD-M201) with a linear range of 0.4-25 ng/mL (QC tested).

Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Cynomolgus IgG1 (AM122) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.95.